Disorders of intermediary metabolism: Toxic leukoencephalopathies

Journal of Inherited Metabolic Disease

Volumn 28, Issue 3, 2005, Pages 345-356

  Horster F ^a   Surtees, R ^a   Hoffmann, Georg F ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYGLUTARIC ACID; 3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 3 HYDROXYBUTYRIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; CARBOXYLIC ACID; CARNITINE; CHOLESTEROL; COBALAMIN; COBALAMIN DERIVATIVE; CREATINE; GLYCINE; KAINIC ACID; LIPID; LYASE; METHYLMALONIC ACID; MIGLUSTAT; MYELIN; MYELIN BASIC PROTEIN; NEUROTOXIN; REACTIVE OXYGEN METABOLITE;

ACIDURIA; BONE MARROW TRANSPLANTATION; BRAIN DISEASE; BRAIN NERVE CELL; BRAIN TOXICITY; CANAVAN DISEASE; CELL INTERACTION; CELL LINEAGE; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENCEPHALOMALACIA; ENERGY METABOLISM; ENZYME DEFICIENCY; ENZYME REPLACEMENT; EXCITOTOXICITY; FABRY DISEASE; GENE INSERTION; GENE THERAPY; GESTATION PERIOD; HUMAN; INBORN ERROR OF METABOLISM; LEUKOENCEPHALOPATHY; LIPOGENESIS; MAPLE SYRUP URINE DISEASE; METABOLIC DISORDER; METHYLMALONIC ACIDURIA; MYELIN SHEATH; MYELINATION; NERVE FIBER; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PHENYLKETONURIA; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT PLANNING; WHITE MATTER;

BRAIN; BRAIN CHEMISTRY; CHOLESTEROL; DEMYELINATING DISEASES; ENERGY METABOLISM; HUMANS; LIPIDS; METABOLISM, INBORN ERRORS; NEUROTOXINS; REACTIVE OXYGEN SPECIES;

EID: 19444385096     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10545-005-2164-5     Document Type: Review

References (52)

1. Albin RL, Greenamyre JT (1992) Alternative excitotoxic hypothesis. Neurology 42: 733-738.
2. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ (1998) Maturation dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18: 6241-6253.
3. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21: 1302-1312.
4. Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC (2002) Arrested oligodendrocyte lineage progression during human cerebral white matter development: Dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 61: 197-211.
5. Baric I, Fumic K, Glenn B, et al (2004) S-Adenosylhomocysteine hydrolase deficiency in a human: A genetic disorder of methionine metabolism. Proc Natl Acad Sci USA 101: 4234-4239.
6. Baslow MH (2002) Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system - an analytical review. Neurochem Int 40: 295-300.
7. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13: 4181-4192.
8. Brismar J, Aqeel A, Brismar G, Coates R, Gascon G, Ozand P (1990) Maple syrup urine disease: Findings on CT and MR scans of the brain in 10 infants. Am J Neuroradiol 11: 1219-1228.
9. Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW (2001) Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 78: 736-745.
10. Dugan LL, Sensi SL, Canzoniero LM, et al (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 15: 6377-6388.
11. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE (2000) NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20: 9235-9241.
12. Follett PL, Deng W, Dai, et al W(2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: A protective role for topiramate. J Neurosci 24(18): 4412-4420.
13. Ghoumari AM, Ibanez C, El-Eltr M, et al (2003) Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 86: 848-859.
14. Goldstein FB (1976) Amidohydrolases of brain; enzymatic hydrolysis of N-acetyl-L-aspartate and other N-acetyl-L-amino acids. J Neurochem 13: 45-49.
15. Greene JG, Porter RHP, Eller RV, Greenamyre JT (1993) Inhibition of succinate dehydrogenase by malonic acid produces an excitotoxic lesion in rat striatum. J Neurochem 61: 1151-1154.
16. Hardy R, Reynolds R (1993) Neuron-oligodendroglial interactions during central nervous system development. Neurosci Res 36: 121-126.
17. Haq E, Giri S, Singh I, Singh AK (2003) Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J Neurochem 86: 1428-1440.
18. Jacobson M (1991) Developmental Neurobiology, 3rd ed. New York: Plenum Press, 776.
19. Jouvet P, Rustin P, Taylor DL (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: Implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11: 1919-1932.
20. Kagawa T, Wada T, Ikenaka K (2001) Regulation of oligodendrocyte development. Microsc Res Tech 52: 740-745.
21. Kavanaugh B, Beesley J, Itoh T, Itoh A, Grinspan J, Pleasure D (2000) Neurotrophin-3 (NT-3) diminishes susceptibility of the oligodendroglial lineage to AMPA glutamate receptor-mediated excitotoxicity. J Neurosci Res 60: 725-732.
22. Kirmani BF, Jacobowitz DM, Kallarakal AT, Namboodiri MA (2002) Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: Therapeutical implications for Canavan disease. Brain Res Mol Brain Res 107: 176-182.
23. Kölker S, Mayatepek E, Hoffmann GF(2002) White matter disease in cerebral organic acid disorders: Clinical implications and suggested pathomechanisms. Neuropediatrics 33: 225-231.
24. Kramer EM, Schardt A, Nave KA (2001) Membrane traffic in myelinating oligodendrocytes. Microsc Res Tech 52: 656-671.
25. Lachmann RH, te Vruchte D, Lloyd-Evans E, et al (2004) Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiol Dis 16: 654-658.
26. Lee CC, Surtees R, Duchen LW (1992) Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase. Brain 115: 935-955.
27. Levine SM, Goldman JE (1988) Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum. J Comp Neurol 277: 441-455.
28. Li C, Tropak, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp B (1994) Myelination in the absence of myelin-associated glycoprotein. Nature 369: 747-750.
29. Madhavaro CN, Moffett JR, Moore RA, Viola RE, Aryan Namboodiri MA, Jacobowitz DM (2004) Immunhistochemical localization of aspartoacylase in the rat central nervous system. J Comp Neurol 472: 318-329.
30. Maggipinto M, Rabiner C, Kidd GJ, Hawkins AJ, Smith R, Barbarese E (2004) Increased expression of the MBP mRNA binding protein HnRNP A2 during oligodendrocyte differentiation. J Neurosci Res 75: 614-623.
31. Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R (1997) Glutamate-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA 94: 8830-8835.
32. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Medicine 4: 291-297.
33. Morell P, Quarles RH, Norton WT (1994) Myelin formation, structure, and biochemistry. In: Siegel GF, ed. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, 5th edn. New York: Raven Press, 117-143.
34. Nyhan WL, Ozand PT (1998) Maple syrup urine disease/branched chain oxoaciduria. In: Atlas of Metabolic Diseases. London: Chapman and Hall Medical, 138-146.
35. Okun JG, Hörster F, Farkas LM, et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic cycle, and synergistically acting excitotoxicity. J Biol Chem 277: 14674-14680.
36. Patneau DK, Wright PW, Winters C, Mayer ML, Gallo V (1994) Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 12: 357-371.
37. Pende M, Holtzclaw LA, Curtis JL, Russell JT, Gallo V (1994) Glutamate regulates intracellular calcium and gene expression in oligodendrocyte progenitors through the activation of DL-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proc Natl Acad Sci USA 91: 3215-3219.
38. Puchalski RB, Louis JC, Brose N, Traynelis SF, Egebjerg J, Kukekov V (1994) Selective RNA editing and subunit assembly of native glutamate receptors. Neuron 13: 131-146.
39. Quarles RH (1997) Glycoproteins of myelin sheaths. J Mol Neu rosci 8: 1-12.
40. Rosenberg PA, Dai W, Gan XD, et al (2003) Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res 71: 237-245.
41. Schulze A (2003) Creatine deficiency syndromes. Mol Cell Biochem 244: 143-150.
42. Scott JM, Dinn JJ, Wilson P, WeirDG(1981) Pathogenesis of subacute combined degeneration: A result of methyl group deficiency. Lancet 15(2; 8242): 334-337.
43. Shefer S, Tint GS, Jean-Guillaume D, et al (2000) Is there a relationship between 3-hydroxy-3 methylglutaryl coenzyme A reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res 61: 549-563.
44. Silberberg D (1969) Maple syrup urine disease metabolites studied in cerebellum cultures. J Neurochem 16: 1141-1146.
45. Surtees R (1998) Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr 157 (supplement 2): S118-S121.
46. Surtees R, Blau N (2000) The neurochemistry of phenylketonuria. Eur J Pediatr 159: S109-113.
47. Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal fluid S-adenosylmethionine in inborn errors of the methyl-transfer pathway. Lancet 338: 1550-1553.
48. Suzuki K, Suzuki K (1995) The twitcher mouse: A model for Krabbe disease and for experimental therapies. Brain Pathol 5: 249-258.
49. van der Knaap MS, Bakker HD, Valk J (1998) MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency. Am J Neuroradiol 19: 378-382.
50. van Hove JLK, Grünewald S, Jaeken J, et al (2003) D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 361: 1433-1435.
51. Volpe JJ (2001) Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50: 553-562.
52. Yonezawa M, Back SA, Gan X, Rosenberg PA, Volpe JJ (1996) Cystine deprivation induces oligodendroglial death: Rescue by free radical scavengers and by a diffusible glial factor. J Neurochem 67: 566-573.